ChemicalBook >
제품 카탈로그 >2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one
|
|
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one 구조식 이미지
|
|
|
- 카스 번호:
- 1367369-77-4
- 상품명:
- 2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one
- 동의어(영문):
- 3’-epi-Entecavir;Entecavir Impurity G;Entecavir impurity C;Entecavir EP Impurity B;Entecavir USP Impurity C;Entecavir (1S,3S,4S) Diastereomer;Entecavir EP Impurity B（USP Impurity C）;Entecavir Impurity 7(Entecavir EP Impurity B);Entecavir Impurity 7 (Entecavir Monohydrate EP Impurity B);2-amino-9-[(1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1~{H}-purin-6-one
- CBNumber:
- CB53050737
- 분자식:
- C12H15N5O3
- 포뮬러 무게:
- 277.28
- MOL 파일:
- 1367369-77-4.mol
|
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one 속성
- 끓는 점
- 661.4±65.0 °C(Predicted)
- 밀도
- 1.81±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 14.22±0.60(Predicted)
안전
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one C화학적 특성, 용도, 생산
용도
An epimeric impurity of the antiviral drug Entecavir (E558900).
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one 준비 용품 및 원자재
원자재
준비 용품
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one 공급 업체
글로벌( 43)공급 업체
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one 관련 검색:
(1'S,3'S,4'S)-엔테카비르이성체 (1S,3S,4R)-엔테카비르 엔테카비르불순물 (1R,3R,4R)-엔테카비르 6-O-벤질-4-데히드록시-4-디메틸페닐실릴엔테카비르
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(benzyloxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanone
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
Entecavir Impurity 32
2-AMino-1,9-dihydro-9-[(1S,3R,4S)-4-(hydroxydiMethylsilyl)-3-(hydroxyMethyl)-2-Methylenecyclopentyl]-6H-purin-6-one
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate
Entecavir
Entecavir Impurity 5
6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine
(1S, 2R)-2-(Benzyloxymethyl)-1-hydroxy-3-cyclopentene
Entecavir Impurity 17(Entecavir EP Impurity C)
2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
